Wednesday, July 8, 2026

pharma · Duchenne Muscular Dystrophy · Gastroparesis · PCSA

Processa Pharmaceuticals

Processa Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Hanover, USA HQ
16 Employees
Public company Type
PCSA · NYSE Ticker
Company details
Status
Public
HQ
Hanover, USA
Employees
16
Programs
8
Drugs
2
Patents
0
Intelligence · Clinical Trials

Processa Pharmaceuticals clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Processa Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Processa Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Processa Pharmaceuticals.

  1. PCS12852 — Phase 2

    Clinical update
  2. HT-100 — Phase 2

    Clinical update
  3. PCS499 — Phase 2

    Clinical update
  4. PCS6422 and capecitabine — Phase 2

    Clinical update
  5. RX-3117 — Phase 2

    Clinical update
  6. RX-3117 — Phase 2

    Clinical update
  7. PCS499 — Phase 1

    Clinical update
  8. PCS6422 and capecitabine — Phase 1

    Clinical update

Trial registry

10 studies